Year archive

ROQUEFORT THERAPEUTICS PLC — 2025 filings

All 31 regulatory filings released by ROQUEFORT THERAPEUTICS PLC (ROQ) in 2025, sourced directly from the official regulator.

31 Filings

2025 Period

2025 filings (31)

Filing	Released	Lang
Clinical Trial & License Agreement Update Regulatory Filings	2025-12-12	English
Conversion of CLNs Regulatory Filings	2025-12-09	English
Ex-Entitlement Date - Unlisted RNV Shares Share Issue/Capital Change	2025-12-01	English
Determination of Record Date and Entitlement Share Issue/Capital Change	2025-12-01	English
Holding(s) in Company Major Shareholding Notification	2025-11-25	English
Director/PDMR Shareholding Director's Dealing	2025-11-24	English
Executed License Agreement & Transaction Update M&A Activity	2025-11-18	English
MK Cell Out-License & Lyramid SPA Update M&A Activity	2025-11-03	English
Fundraise & Transaction Update Capital/Financing Update	2025-10-16	English
Interim Results to 30 June 2025 Interim / Quarterly Report H1 2025	2025-09-30	English
Investor Presentation via Engage Investor Investor Presentation	2025-09-24	English
Proposed Acquisition of Clinical Stage Company M&A Activity	2025-09-08	English
Lyramid SPA 2nd Extension & Carve Out Regulatory Filings	2025-08-28	English
Director/PDMR Shareholding Director's Dealing	2025-07-07	English
Director/PDMR Shareholding Director's Dealing	2025-06-30	English
Lyramid SPA Extension M&A Activity	2025-06-27	English
Results of AGM Declaration of Voting Results & Voting Rights Announcements	2025-06-26	English
Issue of Equity Share Issue/Capital Change	2025-06-13	English
Notice of Annual General Meeting AGM Information	2025-06-02	English
Extension of Convertible Loan Notes Regulatory Filings	2025-05-23	English
2024 Annual Report Annual Report (ESEF) FY 2024	2025-05-20	English
2024 Annual Report Annual Report FY 2024	2025-05-20	English
Corporate Update Regulatory Filings	2025-05-13	English
Annual Report & Financial Statements - 31 Dec 2024 Audit Report / Information FY 2024	2025-04-30	English
Private Placing and Conversion of CLNs Regulatory Filings	2025-03-14	English
Board Changes Board/Management Information	2025-03-10	English
Proposed Sale of Oncogeni Ltd M&A Activity	2025-03-10	English
Update on Sale of Lyramid Regulatory Filings	2025-03-04	English
Director/PDMR Shareholding Director's Dealing	2025-02-04	English
Share Purchase Agreement Signed - Sale of Lyramid Regulatory Filings	2025-02-03	English
Proposed Sale of Midkine Portfolio M&A Activity	2025-01-02	English